Issue Date: February 8, 2016
Luminescent Gold Nanoparticles Track Kidney Disease
Kidney disease is known as a silent killer. That’s because the markers physicians look for to diagnose the disease, such as urea and creatinine levels in the blood, often appear normal even when up to 75% of kidney function has been lost. One inexpensive, noninvasive method for imaging kidneys is to use near-infrared fluorescence imaging to follow an organic dye as it travels through the organs. But such dyes have problems: They often don’t provide . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society